Internal Medicine, Infectious Disease · Houston, TX
NPI
1568551935
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2015 Thomas St
Houston, TX, 77009
Phone (713) 873-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,637
127 services
Medicare patients, 2024
49
Average age 59
Drug cost, 2024
$4.4M
3,719 prescriptions
Company payments, 2023
$59.34
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Penny Jaffe was code 99214 (office e&m - established), 74 times for 40 patients. In total Penny Jaffe billed 127 services in 9 codes, and Medicare paid $6,637.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 74 | 40 | $67.18 | $4,971 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 21 | 19 | $12.52 | $263 |
By year: 2022 $7,122 for 143 services; 2023 $5,992 for 108 services; 2024 $6,637 for 127 services.
Medicare prescription drug claims, 2024
In 2024, the drug Penny Jaffe prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 550 prescriptions and refills. In total Penny Jaffe wrote 3,719 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 550 | 550 | 66 | $2.0M |
| Atorvastatin Calcium Generic | 295 | 609 | 78 | $1,912 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 254 | 259 | 32 | $892K |
| Amlodipine Besylate Generic | 245 | 479 | 57 | $1,237 |
| Hydrochlorothiazide Generic | 144 | 262 | 30 | $358 |
| Tivicay Dolutegravir Sodium | 119 | 119 | 16 | $279K |
| Ritonavir Generic | 105 | 111 | 11 | $12K |
| Darunavir Generic | 103 | 111 | 12 | $50K |
| Lisinopril Generic | 83 | 208 | 26 | $525 |
| Ezetimibe Generic | 77 | 157 | 20 | $712 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 74 | 78 | 13 | $343K |
| Rosuvastatin Calcium Generic | 68 | 136 | 18 | $1,000 |
| Gabapentin Generic | 66 | 78 | 12 | $734 |
| Ibuprofen Generic | 64 | 64 | 14 | $205 |
| Juluca Dolutegravir/Rilpivirine | 60 | 60 | Under 11 | $193K |
Brand drugs: - claims; generic drugs: 2,343 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Penny Jaffe $59.34 ($59.34 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $59.34.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 2 | $59.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.